Cogent Biosciences (COGT) Total Non-Current Liabilities (2017 - 2026)
Cogent Biosciences' Total Non-Current Liabilities came in at $302.07 million for Q2 2026, up 157.2% from $117.42 million a year earlier and up 2.3% from the prior quarter.
Powered by 
Analysis
Cogent Biosciences (COGT) Total Non-Current Liabilities (2017 - 2026) Analysis & Trends
At the end of FY2025, Cogent Biosciences' Total Non-Current Liabilities was $301.2 million, up 320.6% from FY2024.
- Going back by year, Total Non-Current Liabilities was $71.61 million in FY2024.
- The Q2 2026 figure represents the highest quarterly Total Non-Current Liabilities in data going back to Q4 2017.
- Year-over-year, Total Non-Current Liabilities has increased for three consecutive quarters.
- Business Quant data shows COGT's Total Non-Current Liabilities at $295.25 million (Q1 2026), $301.2 million (Q4 2025) and $121.1 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 60.81 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 102.65 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 117.60 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 79.95 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -36.84 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 76.12 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 36.05 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 96.04 Bn |
| 10 | Cogent Biosciences | 5.50 Bn | 2.15 Bn | - | 315.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 315.76 Mn |
| Jun 30, 2026 | 302.07 Mn |
| Mar 31, 2026 | 295.25 Mn |
| Dec 31, 2025 | 301.20 Mn |
| Sep 30, 2025 | 121.10 Mn |
| Jun 30, 2025 | 117.42 Mn |
| Mar 31, 2025 | 64.80 Mn |
| Dec 31, 2024 | 71.61 Mn |
| Dec 31, 2023 | 55.64 Mn |
| Dec 31, 2022 | 43.38 Mn |
| Sep 30, 2022 | 38.56 Mn |
| Jun 30, 2022 | 43.61 Mn |
| Mar 31, 2022 | 15.95 Mn |
| Dec 31, 2021 | 14.85 Mn |
| Sep 30, 2021 | 15.09 Mn |
| Jun 30, 2021 | 12.65 Mn |
| Mar 31, 2021 | 7.79 Mn |
| Dec 31, 2020 | 10.72 Mn |
| Sep 30, 2020 | 150.09 Mn |
| Dec 31, 2018 | 24.95 Mn |
API Access
Cogent Biosciences Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=COGT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "COGT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=COGT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();